Correction to: Effect of sacubitril valsartan on heart failure with mid-range or preserved ejection fraction in patients on maintenance hemodialysis: real-world experience in a single-center, prospective study
Xiao-mei Huang, Jing-jing Li, Wang Yin, Hui-ling Fu, Fen Yu, Lian-qing Gu, Yi Zhang, Min Du, Zheng Ye, Li Xu
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsHeart Failure Treatment and Management
Correction to: BMC Cardiovascular Disorders (2024) 24:1
10.1186/s12872-024-03744-y.
Following publication of the original article [1], author Li Xu also should have been denoted as a corresponding author.
The original article has been corrected.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Huang X Li J Yin W Effect of sacubitril valsartan on heart failure with mid-range or preserved ejection fraction in patients on maintenance hemodialysis: real-world experience in a single-center, prospective study BMC Cardiovasc Disord 2024247910.1186/s 12872-024-03744-y 38291395 PMC 10826098 · doi ↗ · pubmed ↗